Cargando…
Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease
Autores principales: | Zaza, Gianluigi, Stallone, Giovanni, Granata, Simona, Gentile, Micaela, Panico, Maddalena, Bin, Sofia, Wang, Lin, Rollenhagen, Christiane, Maltzman, Jonathan S., Cravedi, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148717/ https://www.ncbi.nlm.nih.gov/pubmed/37360818 http://dx.doi.org/10.1016/j.ekir.2023.04.026 |
Ejemplares similares
-
Differences in Humoral and Cellular Vaccine Responses to SARS-CoV-2 in Kidney and Liver Transplant Recipients
por: Furian, Lucrezia, et al.
Publicado: (2022) -
SARS-CoV2 vaccine boosters for India
por: Kang, Gagandeep
Publicado: (2022) -
Humoral response to SARS-CoV-2 after vaccination and booster effect in patients undergoing dialysis
por: Hernández-Porto, Miriam, et al.
Publicado: (2022) -
Antibody response to SARS-CoV-2 booster vaccines
por: Loving, Hanna S., et al.
Publicado: (2022) -
Humoral response after SARS-CoV-2 booster vaccination in haemodialysis patients with and without prior infection
por: Füessl, Louise, et al.
Publicado: (2022)